Mikart Partners with Fluid Pharma to Advance the Application of MicroCoat Technology
Will manufacture clinical trial materials using proprietary MicroCoat technology to advance new therapies. ATLANTA and HERTFORDSHIRE, England, Oct. 19, 2022 /PRNewswire/ — Mikart, LLC (“Mikart”) a...
Mikart Announces Validation of its New Liquid and Suspension Suite
ATLANTA, March 11, 2024 /PRNewswire/ — Mikart LLC, a leading contract development and manufacturing company, proudly announces the successful validation of its...
Home
Our newsletter Be the first to receive our latest news and updates.
Mikart Expands Oral Solid Dose Manufacturing Capabilities
ATLANTA, Feb. 15, 2024 /PRNewswire/ — Mikart, LLC, a leading Contract Development and Manufacturing Organization (CDMO), announces the addition of cutting-edge, Fette® double-sided...
What does it mean to be 2023 serialization compliant?
Mikart is 2023 compliant, offering unit-level traceability and aggregation from the lowest unit of sale to the pallet. Although aggregation is only expected to become mandatory and fully applied in 2023, and while some are waiting for mandates for traceability, serialization, and aggregation, Mikart chose to implement this requirement early to provide our customers with the ease of scanning pallets and providing them quickly with the data needed for inventory management.
Careers
Please be aware of scammers; — Scammers promise you a job, but they are trying to get your personal information....
Solvent to Aqueous Switches
When I first started my career in the pharmaceutical industry back in 1986, I would find lots of strange looking...
Who We Are
Our Mission At Mikart, our mission is to leverage our technical expertise in pharmaceutical development and manufacturing to deliver services...